RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Eli Lilly and ROA 2024

Eli Lilly and ROA

0.08

Eli Lilly and Dividend yield

0.61 %

Ticker

LLY

ISIN

US5324571083

WKN

858560

In 2024, Eli Lilly and's return on assets (ROA) was 0.08, a -35.12% increase from the 0.13 ROA in the previous year.

Eli Lilly and Aktienanalyse

What does Eli Lilly and do?

Eli Lilly and Co. is a global biopharmaceutical company headquartered in Indianapolis, Indiana, USA. The company was founded in 1876 by Colonel Eli Lilly with the aim of manufacturing pharmaceutical products of the highest quality. Eli Lilly began his career in the pharmacy industry and opened his own pharmacy in Indianapolis in 1876. He quickly developed his own medications and eventually established Eli Lilly and Company in 1901. Over the years, the company has continued to evolve and expand its business into numerous areas. Eli Lilly is focused on biopharmaceutical research and development and operates in areas such as oncology, diabetes, neurology, and others. The company's main goal is to develop drugs that can change and improve lives. Eli Lilly invests a high percentage of its revenue into research and development every year. The company has several strategic business units, including human pharmaceuticals, animal pharmaceuticals, and oncology research. Eli Lilly is divided into five main divisions: diabetes, oncology, immunology, neurology, and animal health. The diabetes division focuses on manufacturing insulin products and glucose sensors for the treatment of type 1 and type 2 diabetes, as well as blood glucose meters and other diabetes products. The oncology division focuses on researching and developing drugs to treat cancer. The company currently has several compounds in clinical trials, including a new preparation for the treatment of breast cancer. The immunology division focuses on products for the treatment of autoimmune and inflammatory diseases, such as psoriasis. The neurology division focuses on researching and developing drugs to treat diseases of the nervous system, such as Alzheimer's. The animal health division focuses on animal health products, such as drugs for the treatment of infections in livestock and pets. Eli Lilly is primarily known for its insulin products and treatments in the field of oncology. Some of the company's most well-known products include Humalog, Forteo, Alimta, and Cymbalta. The effectiveness and compliance of the products are monitored by a quality and safety system to ensure that patients receive the highest quality medications. In conclusion, Eli Lilly and Co. is a company with a long history and a unique business model. The company specializes in developing high-quality pharmaceutical products and has continued to evolve since its founding. Eli Lilly has become a leader in various areas such as diabetes, oncology, immunology, neurology, and animal health. They are known for their insulin products and treatments in the field of oncology. The company remains committed to expanding its reach and presence globally and continues to develop innovative products that can improve and change people's lives. Eli Lilly and ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Eli Lilly and's Return on Assets (ROA)

Eli Lilly and's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Eli Lilly and's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Eli Lilly and's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Eli Lilly and’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Eli Lilly and Stock

What is the Return on Assets (ROA) of Eli Lilly and this year?

The Return on Assets (ROA) of Eli Lilly and is 0.08 undefined this year.

What was the ROA of Eli Lilly and compared to the previous year?

The ROA of Eli Lilly and has increased by -35.12% compared to the previous year.

What consequences do high ROA have for investors of Eli Lilly and?

A high ROA is advantageous for investors of Eli Lilly and, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Eli Lilly and?

A low ROA can be unfavorable for investors of Eli Lilly and as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Eli Lilly and affect the company?

An increase in ROA of Eli Lilly and can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Eli Lilly and impact the company?

A reduction in the ROA of Eli Lilly and can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Eli Lilly and?

Some factors that can influence the ROA of Eli Lilly and include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Eli Lilly and important for investors?

The ROA of Eli Lilly and is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Eli Lilly and take to improve ROA?

To improve ROA, Eli Lilly and can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Eli Lilly and pay?

Over the past 12 months, Eli Lilly and paid a dividend of 4.52 USD . This corresponds to a dividend yield of about 0.61 %. For the coming 12 months, Eli Lilly and is expected to pay a dividend of 5.73 USD.

What is the dividend yield of Eli Lilly and?

The current dividend yield of Eli Lilly and is 0.61 %.

When does Eli Lilly and pay dividends?

Eli Lilly and pays a quarterly dividend. This is distributed in the months of June, September, December, March.

How secure is the dividend of Eli Lilly and?

Eli Lilly and paid dividends every year for the past 26 years.

What is the dividend of Eli Lilly and?

For the upcoming 12 months, dividends amounting to 5.73 USD are expected. This corresponds to a dividend yield of 0.77 %.

In which sector is Eli Lilly and located?

Eli Lilly and is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eli Lilly and kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eli Lilly and from 3/8/2024 amounting to 1.3 USD, you needed to have the stock in your portfolio before the ex-date on 2/14/2024.

When did Eli Lilly and pay the last dividend?

The last dividend was paid out on 3/8/2024.

What was the dividend of Eli Lilly and in the year 2023?

In the year 2023, Eli Lilly and distributed 3.92 USD as dividends.

In which currency does Eli Lilly and pay out the dividend?

The dividends of Eli Lilly and are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Eli Lilly and stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Eli Lilly and

Our stock analysis for Eli Lilly and Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eli Lilly and Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.